Andrés F. Henao-Martínez, MD

University of Colorado Anschutz Medical Campus

Disclosure(s): No financial relationships to disclose

Poster(s):

• 249 - Characteristics and outcomes of cryptococcosis among patients with COVID-19 compared to non-COVID-19 controls
  Thursday, October 20, 2022

  12:15 PM – 1:30 PM US ET

• 356 - Risk Assessment of Pneumocystis jirovecii Pneumonia among Hospitalized Patients with Hypoxic Respiratory Failure - A Proposed Multivariable Calculator Based on Previous Prednisone Equivalent Dose
  Thursday, October 20, 2022

  12:15 PM – 1:30 PM US ET

• 370 - Toxoplasma gondii IgG Seropositivity is Associated with Increased Schizophrenia, Hospitalization, and 1-year Mortality— a Multicenter Research Network Study
  Thursday, October 20, 2022

  12:15 PM – 1:30 PM US ET

• 472 - Corticosteroid Exposure as a Risk Factor for Pneumocystis jirovecii Pneumonia Mortality in HIV-Negative Patients: A Multicenter Retrospective Case-Control Study with a Global Research Network Validation
  Thursday, October 20, 2022

  12:15 PM – 1:30 PM US ET

• 473 - Diabetes Mellitus as a Risk Factor for Cryptococcosis — a Multicenter Research Network Study
  Thursday, October 20, 2022

  12:15 PM – 1:30 PM US ET

• 1383 - Necrotizing Fasciitis and Streptococcus pyogenes (GAS) Infection Seasonality and Risk Factors for Infection— a Multicenter Research Network Study
  Friday, October 21, 2022

  12:15 PM – 1:30 PM US ET

• 1829 - Dalbavancin versus standard of care as directed therapy for Staphylococcus aureus bacteremia in patients unable to receive OPAT
  Saturday, October 22, 2022

  12:15 PM – 1:30 PM US ET